RxDoctor Payments Data

Rebecca Pope, NP

Family · Carrollton, GANPI 1578985271

Payments from drug & device makers

$1,209in general payments, 2019–2025

Across 72 payments — averaging $16.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Scilex Pharmaceuticals Inc.$325
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$258
  • Collegium Pharmaceutical, Inc.$225
  • Hikma Pharmaceuticals USA$120
  • Almatica Pharma LLC$71
  • Biodelivery Sciences International, Inc.$65
  • plus $145 from 5 others

What the payments were for

  • Food & beverage$1,209100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,209 in reported general payments places this provider in the 70th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$60,932
Medicare patients
63
Services billed
453

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl42$38,275
MovantikNaloxegol Oxalate26$18,251
ZtlidoLidocaine18$13,020
Buprenorphine27$10,016
Lidocaine43$7,189
Gabapentin349$4,537
Diclofenac Sodium71$1,874
Pregabalin124$1,568
Tizanidine Hcl183$1,179
Methocarbamol80$907
Naloxone Hcl14$894
Baclofen64$803
Cyclobenzaprine Hcl162$709
Omega-3 Acid Ethyl Esters13$675
Duloxetine Hcl49$517

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca$225$38,27542 claims
Redhill Biopharma Inc.Movantik$14$18,25126 claims
Scilex Pharmaceuticals Inc.Ztlido$325$13,02018 claims
Hikma Pharmaceuticals USABuprenorphine$120$10,01627 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 6,258 family providers in Georgia.

Other family in Carrollton

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →